Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Repaglinide vs Combination in Type 2 Diabetes
NCT01465152Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2002
- Primary completion
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of repaglinide in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Mar 2002; status: completed.
02
Drugs
repaglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01465152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01465152.